Literature DB >> 9426521

Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.

M R Wick1, D M Ockner, S E Mills, J H Ritter, P E Swanson.   

Abstract

Morphologic mimicry among human malignant neoplasms is a well-known phenomenon in surgical pathology; both undifferentiated and "committed" neoplasms may exhibit this trait. One particularly common group of histologic simulants includes ductal carcinomas of the breasts, the cutaneous appendages, and the salivary glands. One hundred three tumors in this structural cluster were analyzed microscopically and immunohistologically to codify points of potential pathologic similarity and difference. All the lesions were typified by irregularly permeative clusters and cords of atypical polygonal cells with variable luminal differentiation. A proportion of primary neoplasms in each site demonstrated in situ ductal components; in the absence of the latter elements, however, it was not possible to make topography-related morphologic distinctions among them. Immunostains for gross cystic disease fluid protein-15 (GCDFP-15), carcinoembryonic antigen, S100 protein, c-erbB-2 oncoprotein, estrogen receptor protein, and progesterone receptor protein also showed largely overlapping phenotypes in each of the three tumor categories, with selected exceptions. These differences were elucidated through paired chi 2 analysis and included a statistically significant infrequency of GCDFP-15 in eccrine sweat gland carcinomas, a paucity of carcinoembryonic antigen in breast cancers, and an absence of estrogen receptor protein in salivary duct carcinomas. Such findings may be useful in predefined differential diagnostic settings involving the distinction between primary and metastatic ductal cancers of the breasts, skin, and salivary glands. Nevertheless, because of the striking homologies between such tumors at structural and protein-synthetic levels of comparison, it is mandatory that all available clinicopathologic information be used in this context.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9426521     DOI: 10.1093/ajcp/109.1.75

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  27 in total

1.  Salivary duct carcinoma with neuroendocrine features.

Authors:  Juan B Laforga
Journal:  Virchows Arch       Date:  2004-03-11       Impact factor: 4.064

2.  Salivary duct carcinoma of the extra-glandular segment of Stensen's duct: radiological findings and pathological correlation (2008: 10b).

Authors:  Fumito Okada; Koichi Honda; Yumiko Ando; Tomoko Nakayama; Michiaki Sai; Shuichi Tanoue; Shunro Matsumoto; Hiromu Mori
Journal:  Eur Radiol       Date:  2009-01-19       Impact factor: 5.315

Review 3.  Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Authors:  Roderick H W Simpson
Journal:  Head Neck Pathol       Date:  2013-07-03

4.  Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.

Authors:  Jalal B Jalaly; Souzan Sanati; Rebecca D Chernock; Dikson G Dibe; Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2018-01-04

Review 5.  Sweat gland progenitors in development, homeostasis, and wound repair.

Authors:  Catherine Lu; Elaine Fuchs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

Review 6.  Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.

Authors:  Masato Nakaguro; Yuichiro Tada; William C Faquin; Peter M Sadow; Lori J Wirth; Toshitaka Nagao
Journal:  Cancer Cytopathol       Date:  2020-05-18       Impact factor: 5.284

Review 7.  [Salivary duct carcinoma].

Authors:  D Hungermann; K Roeser; H Buerger; T Jäkel; T Löning; H Herbst
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

8.  Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells.

Authors:  R L Houghton; D C Dillon; D A Molesh; B K Zehentner; J Xu; J Jiang; C Schmidt; A Frudakis; E Repasky; A Maltez Filho; M Nolasco; R Badaro; X Zhang; P C Roche; D H Persing; S G Reed
Journal:  Mol Diagn       Date:  2001-06

9.  GATA3 immunohistochemical expression in salivary gland neoplasms.

Authors:  Lauren E Schwartz; Shahnaz Begum; William H Westra; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2013-04-20

10.  A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement.

Authors:  Charles F Streckfus; Karen A Storthz; Lenora Bigler; William P Dubinsky
Journal:  J Oncol       Date:  2009-12-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.